
Dozens of Republicans To Skip Dallas Convention, Distancing Themselves From Trump Amid Competitive Races
By JOSEPH CURL
|This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.

Published:
Updated:
In a case that is bound to have ripple effects for years to come, a state court judge in Oklahoma last week held that Johnson & Johnson must pay half a billion dollars to the state government as penance for manufacturing and marketing prescription pain medication. Many are hailing the judgment as a proper comeuppance for the pharmaceutical industry.

By JOSEPH CURL
|
By JOSH HAMMER
|
By DAVID HARSANYI
|
By ALEXANDER LARMAN
|
By DAVID JONES
|
By JOSEPH CURL
|
By JOSEPH CURL
|
By GEORGE WILLIS
|In a case that is bound to have ripple effects for years to come, a state court judge in Oklahoma last week held that Johnson & Johnson must pay half a billion dollars to the state government as penance for manufacturing and marketing prescription pain medication. Many are hailing the judgment as a proper comeuppance for the pharmaceutical industry.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.